Resultados de la búsqueda

Trerotola M, Relli V, Tripaldi R, Simeone P, Guerra E, Sacchetti A, Ceci M, Pantalone L, Ciufici P, Moschella A, Caiolfa VR, Zamai M, Alberti S. Large, recursive membrane platforms are associated to Trop-1, Trop-2, and protein kinase signaling for cell growth. Mol Biol Cell (2025) 36:ar38

Forte-Castro A, Pérez JM, Domene MA, Ovejero-Paredes K, Filice M, Fernández I. Design and characterization of a multifunctional Ag/Ag(I)-coated olive stone material for enhanced preservation and antibacterial protection. Food Packag Shelf Life (2025) 49

Aboy-Pardal MCM, Guadamillas MC, Guerrero CR, Català-Montoro M, Toledano-Donado M, Terrés-Domínguez S, Pavón DM, Jiménez-Jiménez V, Jimenez-Carretero D, Zamai M, Folgueira C, Cerezo A, Lolo FN, Nogueiras R, Sabio G, Sánchez-Álvarez M, Echarri A, Garcia R, Del Pozo MA. Plasma membrane remodeling determines adipocyte expansion and mechanical adaptability. Nat Commun (2024) 15:10102
Repisalud

de la Cabeza Fernández M, Sánchez M, Lozano-Chamizo L, Cristina Abreu A, Anguís-Morillas A, Divakar PK, Marciello M, Filice M, Gonzalez-Rumayor V, Fernández I, Contreras-Cáceres R, Gómez-Serranillos P. Electrospun nanofibers for localized drug release of a neuroprotective natural extract of Usnea ghattensis. EUR J PHARM BIOPHARM (2024) 205:114552:114552

Saiz ML, Lozano-Chamizo L, Florez AB, Marciello M, Diaz-Bulnes P, Corte-Iglesias V, Bernet CR, Rodrigues-Diez RR, Martin-Martin C, Rodriguez-Santamaria M, Fernandez-Vega I, Rodriguez RM, Diaz-Corte C, Suarez-Alvarez B, Filice M, Lopez-Larrea C. BET inhibitor nanotherapy halts kidney damage and reduces chronic kidney disease progression after ischemia-reperfusion injury. Biomed Pharmacother (2024) 174:116492
Link to the full text in Repisalud

Iorhemba MA, Álvarez-Conde J, Díaz-García D, Méndez-Arriaga JM, García-Almodóvar V, Ovejero-Paredes K, Idris SO, Shallangwa GA, Abdulkadir I, Prashar S, Filice M, Gómez-Ruiz S. Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer. BIOMED MATER (2024) 19

Iorhemba MA, Ovejero-Paredes K, Díaz-García D, García-Almodóvar V, Idris SO, Shallangwa GA, Abdulkadir I, Méndez-Arriaga JM, Prashar S, Filice M, Gómez-Ruiz S. Amino acid-decorated mesoporous silica nanoparticles loaded with titanocene derivatives for targeted anticancer studies. APPL ORGANOMET CHEM (2024) 38
Link to the full text in Repisalud

García-Almodóvar V, Ovejero-Paredes K, Díaz-García D, Méndez-Arriaga JM, Prashar S, Filice M, Gómez-Ruiz S. Albumin-Loaded Silica Nanomaterials Functionalized with Organotin(IV) Agents: Theranostic Materials Against Triple-Negative Breast Cancer. ADV THER (2024) 7:1-12

Carramolino L, Albarrán-Juárez J, Markov A, Hernández-SanMiguel E, Sharysh D, Cumbicus V, Morales-Cano D, Labrador-Cantarero V, Loof Møller P, Nogales P, Benguria A, Dopazo A, Sanchez-Cabo F, Torroja C, Bentzon JF. Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes. Nature Cardiovascular Research (2024) 3:203-220.

Orsi A, van Anken E, Vitale M, Zamai M, Caiolfa VR, Sitia R, Bakunts A. Congress of multiple dimers is needed for cross-phosphorylation of IRE1α and its RNase activity. Life Sci Alliance (2024) 7:e202302562
Link to the full text in Repisalud